HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial
Titel:
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial
Auteur:
Guarneri, Valentina Brasó-Maristany, Fara Dieci, Maria Vittoria Griguolo, Gaia Paré, Laia Marín-Aguilera, Mercedes Miglietta, Federica Bottosso, Michele Giorgi, Carlo Alberto Blasco, Paula Castillo, Oleguer Galván, Patricia Vivancos, Ana Villagrasa, Patricia Parker, Joel S. Perou, Charles M. Conte, PierFranco Prat, Aleix